Bupropion vs Rosuvastatin: side-by-side comparison
Bupropion (Norepinephrine-dopamine reuptake inhibitor (NDRI) antidepressant) and Rosuvastatin (HMG-CoA reductase inhibitor (statin)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Bupropion | Rosuvastatin |
|---|---|---|
| Therapeutic class | Norepinephrine-dopamine reuptake inhibitor (NDRI) antidepressant | HMG-CoA reductase inhibitor (statin) |
| CAS | 34911-55-2 | 287714-41-4 |
| ATC | N06AX12 | C10AA07 |
| Molecular weight | 239.74 g/mol | 481.54 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Bupropion and Rosuvastatin share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Bupropion acts by a different mechanism than Rosuvastatin, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Bupropion: Le bupropion inhibe la recapture de la noradrénaline et de la dopamine, avec un effet nettement plus faible sur la recapture de la sérotonine. Rosuvastatin: La rosuvastatine inhibe de façon compétitive l'HMG-CoA réductase, enzyme limitante de la synthèse hépatique du cholestérol.
Indications compared
Bupropion: Le bupropion est autorisé dans la dépression caractérisée, la prévention des récidives de trouble affectif saisonnier et le sevrage tabagique. Rosuvastatin: La rosuvastatine est autorisée chez l'adulte dans l'hypercholestérolémie primaire et la dyslipidémie mixte, dans la prévention des événements cardiovasculaires chez les patients à risque élevé et en prévention secondaire…
Safety profile
Bupropion: Les effets indésirables fréquents comprennent sécheresse buccale, insomnie, céphalées, agitation, nausées et perte de poids. Rosuvastatin: Les effets indésirables fréquents comprennent myalgies, troubles digestifs, céphalées et élévation modérée des transaminases.
Questions fréquentes
Is Bupropion better than Rosuvastatin? ▾
Bupropion and Rosuvastatin are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Bupropion and Rosuvastatin be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Bupropion
Products with Rosuvastatin
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.